Cargando…
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304173/ https://www.ncbi.nlm.nih.gov/pubmed/28211903 http://dx.doi.org/10.1038/srep42470 |
_version_ | 1782506839878926336 |
---|---|
author | Malnati, Mauro S. Ugolotti, Elisabetta Monti, Maria Cristina Battista, Davide De Vanni, Irene Bordo, Domenico Sironi, Francesca Larghero, Patrizia Marco, Eddi Di Biswas, Priscilla Poli, Guido Vicenzi, Elisa Riva, Agostino Tarkowski, Maciej Tambussi, Giuseppe Nozza, Silvia Tripodi, Gino Marras, Francesco Maria, Andrea De Pistorio, Angela Biassoni, Roberto |
author_facet | Malnati, Mauro S. Ugolotti, Elisabetta Monti, Maria Cristina Battista, Davide De Vanni, Irene Bordo, Domenico Sironi, Francesca Larghero, Patrizia Marco, Eddi Di Biswas, Priscilla Poli, Guido Vicenzi, Elisa Riva, Agostino Tarkowski, Maciej Tambussi, Giuseppe Nozza, Silvia Tripodi, Gino Marras, Francesco Maria, Andrea De Pistorio, Angela Biassoni, Roberto |
author_sort | Malnati, Mauro S. |
collection | PubMed |
description | Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia. |
format | Online Article Text |
id | pubmed-5304173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53041732017-03-14 Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control Malnati, Mauro S. Ugolotti, Elisabetta Monti, Maria Cristina Battista, Davide De Vanni, Irene Bordo, Domenico Sironi, Francesca Larghero, Patrizia Marco, Eddi Di Biswas, Priscilla Poli, Guido Vicenzi, Elisa Riva, Agostino Tarkowski, Maciej Tambussi, Giuseppe Nozza, Silvia Tripodi, Gino Marras, Francesco Maria, Andrea De Pistorio, Angela Biassoni, Roberto Sci Rep Article Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia. Nature Publishing Group 2017-02-13 /pmc/articles/PMC5304173/ /pubmed/28211903 http://dx.doi.org/10.1038/srep42470 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Malnati, Mauro S. Ugolotti, Elisabetta Monti, Maria Cristina Battista, Davide De Vanni, Irene Bordo, Domenico Sironi, Francesca Larghero, Patrizia Marco, Eddi Di Biswas, Priscilla Poli, Guido Vicenzi, Elisa Riva, Agostino Tarkowski, Maciej Tambussi, Giuseppe Nozza, Silvia Tripodi, Gino Marras, Francesco Maria, Andrea De Pistorio, Angela Biassoni, Roberto Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control |
title | Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control |
title_full | Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control |
title_fullStr | Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control |
title_full_unstemmed | Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control |
title_short | Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control |
title_sort | activating killer immunoglobulin receptors and hla-c: a successful combination providing hiv-1 control |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304173/ https://www.ncbi.nlm.nih.gov/pubmed/28211903 http://dx.doi.org/10.1038/srep42470 |
work_keys_str_mv | AT malnatimauros activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT ugolottielisabetta activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT montimariacristina activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT battistadavidede activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT vanniirene activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT bordodomenico activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT sironifrancesca activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT largheropatrizia activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT marcoeddidi activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT biswaspriscilla activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT poliguido activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT vicenzielisa activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT rivaagostino activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT tarkowskimaciej activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT tambussigiuseppe activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT nozzasilvia activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT tripodigino activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT marrasfrancesco activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT mariaandreade activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT pistorioangela activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control AT biassoniroberto activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control |